Global coagulation assay parameters | Units | Normal controls (n = 153) | All Diabetics (n = 184) | P values* |
---|---|---|---|---|
Thromboelastography: Maximum amplitude, median (IQR) | mm | 60.5 (57.2, 63.5) | 69.0 (66.1, 72.6) | <0.001 |
CAT: Endogenous thrombin potential, median (IQR) | nm.min | 1320 (1164, 1510) | 1260 (1097, 1460) | 0.061 |
CAT: Peak height, median (IQR) | nm | 220.3 (173, 266.8) | 211.3 (173.5, 256.0) | 0.92 |
OHP: Overall coagulation potential, mean (SD) | unit | 35.5 (9.7) | 41.1 (10.3) | <0.001 |
OHP: Overall fibrinolytic potential, median (IQR) | % | 81.1 (77.4, 84.1) | 73.3 (65.1, 79.5) | <0.001 |
Biomarkers: TFPI, median (IQR) | ng/mL | 14.5 (6.7, 27.6) | 37.1 (2.1, 71.4) | <0.001 |
Biomarkers: PAI‐1, median (IQR) | ng/mL | 8.1 (2.8, 18.5) | 9.9 (4.5, 20.0) | 0.14 |